Many U.S. hospitals using predictive models are not evaluating their tools internally for accuracy, and fewer still are evaluating them for potential biases, according to a study published in the most ...

Peter Salgo, MD, and John L. Fox, MD, MHA, discuss the definition of predictive value of diagnostic testing in cancer and describe the value of the genomic assays that are currently available in ...

Antoni Ribas, MD, PhD: For certain cancers where we know it can only work in a specific situation that has a specific marker, having a companion diagnostic makes a lot of sense. You want to select ...

Traditional testing, though valuable, is often reactive and identifies quality issues only after they have occurred. This can lead to project delays and financial and reputational losses. In fact, ...

Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis™ Breast CTX, a new predictive capability within its Ataraxis Breast ...